

[ Mon, Jan 30th 2023
] - WOPRAI
[ Mon, Jan 30th 2023
] - WOPRAI
[ Mon, Jan 30th 2023
] - WOPRAI
[ Mon, Jan 30th 2023
] - WOPRAI
[ Mon, Jan 30th 2023
] - WOPRAI
[ Mon, Jan 30th 2023
] - WOPRAI
[ Mon, Jan 30th 2023
] - WOPRAI
[ Mon, Jan 30th 2023
] - WOPRAI

[ Sun, Jan 29th 2023
] - WOPRAI
[ Sun, Jan 29th 2023
] - WOPRAI

[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
Michael Ulz Downgraded (TSHA) to Hold and Held Target at $3 on, Jan 27th, 2023
Michael Ulz of Morgan Stanley, Downgraded "Taysha Gene Therapies, Inc." (TSHA) to Hold and Held Target at $3 on, Jan 27th, 2023.
Michael has made no other calls on TSHA in the last 4 months.
There are 7 other peers that have a rating on TSHA. Out of the 7 peers that are also analyzing TSHA, 1 agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Salveen Richter of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $3 on, Wednesday, November 9th, 2022
These are the ratings of the 6 analyists that currently disagree with Michael
- Silvan Tuerkcan of "JMP Securities" Maintained at Buy with Decreased Target to $6 on, Thursday, January 19th, 2023
- Yanan Zhu of "Wells Fargo" Maintained at Buy with Decreased Target to $10 on, Wednesday, January 4th, 2023
- Geulah Livshits of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $16 on, Wednesday, November 9th, 2022
- Gil Blum of "Needham" Maintained at Strong Buy with Decreased Target to $16 on, Wednesday, November 9th, 2022
- Whitney Ijem of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $16 on, Tuesday, November 8th, 2022
- Jack Allen of "Baird" Maintained at Buy with Decreased Target to $21 on, Wednesday, October 26th, 2022
Contributing Sources